Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Parasomnias × Cannabidiol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 3 Colonic Neoplasms 3 Breast Neoplasms 3 Sturge-Weber Syndrome 2 Seizures 2 Nausea 2 Marijuana Abuse 2 Glioblastoma 2 Anxiety Disorders 2 Vomiting 1 Solid Tumor 1 Rectal Neoplasms 1 Parasomnias 1 Pancreatic Neoplasms 1 Pain 1 Neoplasms 1 Multiple Myeloma 1 Liver Neoplasms 1 Liver Cirrhosis 1 Lennox Gastaut Syndrome 1 Gallbladder Neoplasms 1 Epilepsies, Myoclonic 1 Dysgeusia 1 Drug Resistant Epilepsy 1 Colorectal Neoplasms 1 Cognitive Dysfunction 1 Chemotherapy-Induced Peripheral Neuropathy 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1 Cancer Pain 1

Interventions

Melatonin 4 Surveys and Questionnaires 3 Yoga 2 Exercise 2 Control Groups 2 nabiximols 1 Walking 1 Ultraviolet Therapy 1 Tai Ji 1 Sugars 1 Respiration 1 Relaxation Therapy 1 Qigong 1 Modafinil 1 Minocycline 1 Mindfulness 1 Massage 1 Exercise Movement Techniques 1 Dronabinol 1 Cannabidiol 1 Breathing Exercises 1 Autogenic Training 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03948074 2025-09-10

CAFCARS

British Columbia Cancer Agency

Phase 2 Completed

Anxiety Disorders, Nausea, Pain, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡